Scientists Are Developing a Sensor That Could Spot Osteoarthritis Earlier
University of Brighton researchers are testing a new electrochemical sensor designed to detect chemical changes linked to osteoarthritis before irreversible joint damage develops.
New Osteoarthritis Sensor Could Open the Door to Earlier Detection
For people living with osteoarthritis, one of the biggest challenges is that diagnosis can come after changes in the joint have already developed. Now, researchers at the University of Brighton are investigating whether a tiny chemical sensor could help identify signs of the disease much earlier.
The project, officially titled the “Development of an ROS/RNS sensor for the early detection of osteoarthritis,” is being led by Professor Katherine Staines, with Professor Bhavik Patel and Dr Lisa Mullen as co-investigators. University records show the research project began in April 2026 and is scheduled to run until May 2027.
The idea is both simple and ambitious: instead of waiting for visible structural changes in a joint, researchers want to investigate whether chemical signals could provide an earlier warning.
Looking for the Earliest Signals
Osteoarthritis is a progressive musculoskeletal disease involving changes to cartilage, bone and other tissues around a joint. Researchers have spent years trying to understand what happens at the earliest stages of the disease, when biological changes may occur before obvious structural deterioration.
Professor Staines’ research focuses specifically on the molecular mechanisms involved in osteoarthritis and other musculoskeletal conditions. Her work includes investigating how osteoarthritis develops and how earlier biological indicators might eventually contribute to better approaches to prevention and treatment.
The new sensor project focuses on reactive oxygen species and reactive nitrogen species, commonly abbreviated as ROS and RNS. These molecules are involved in normal biological processes, but changes in their levels can also be associated with cellular stress and disease-related processes.
The researchers are exploring whether measuring these chemical signals could provide useful information about osteoarthritis before major joint damage becomes apparent.
Why Earlier Detection Matters
Today, doctors use a combination of symptoms, physical examinations and imaging to assess joint problems. Imaging can be extremely valuable, but researchers are interested in finding biological indicators that might reveal disease activity at an earlier stage.
That distinction matters because osteoarthritis is not simply a problem that appears suddenly when someone begins experiencing pain. Biological and structural changes can develop over time.
The University of Brighton describes the sensor as a potential way of detecting osteoarthritis before irreversible joint damage occurs. However, that remains a research goal rather than a proven clinical capability. The current project is intended to develop and investigate the technology before any future use in routine healthcare.
A Chemical Window Into Joint Health
The technology being investigated is electrochemical sensing. In broad terms, electrochemical sensors can detect chemical signals by measuring electrical responses associated with particular substances.
For this project, researchers are interested in whether the technology can detect patterns involving ROS and RNS that could eventually become useful biomarkers of osteoarthritis.
If the approach proves successful, it could provide scientists with a new way to study what is happening inside an affected joint.
That could also have implications beyond diagnosis. Reliable biomarkers are valuable in medical research because they can help researchers understand whether a treatment is changing the underlying disease process rather than simply reducing symptoms.
Still Early, But Potentially Important
It is important not to confuse an experimental sensor with a medical test that patients can currently request.
The University of Brighton project is active research. Its purpose is to investigate and develop the technology, and further testing would be required before determining whether such a sensor could reliably detect osteoarthritis in patients.
That process could involve laboratory validation, clinical studies, assessments of accuracy and comparisons with existing diagnostic approaches.
Still, the research represents an interesting direction in osteoarthritis research: looking for measurable biological signals that could appear before advanced structural damage.
The long-term possibility is an earlier and more detailed picture of joint health.
If researchers can demonstrate that particular chemical patterns reliably correspond with early osteoarthritis, future studies could investigate whether those measurements can help doctors identify people at greater risk, monitor disease progression or evaluate potential treatments.
That could eventually shift some aspects of osteoarthritis care toward earlier intervention.
But there is a considerable distance between a promising research concept and an approved clinical test. The Brighton team first needs to establish whether the sensor can produce reliable, meaningful results.
For now, the research offers a glimpse into how future healthcare could become more focused on detecting disease biology before extensive damage occurs.
The University of Brighton’s work does not yet promise a cure or a routine screening test. What it does provide is a compelling research question: could the chemistry of a joint reveal osteoarthritis before the damage becomes obvious?
The answer is still being investigated—but researchers are now building the technology that could help find it.
Photo by Anna Auza on Unsplash
About Wellcore Weekly: Wellcore Weekly covers health, wellness, nutrition, sleep, fitness, and medical research with timely, easy-to-understand updates for everyday readers.
